Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism
Rebecca J Schmidt1, Robin L Hansen, Jaana Hartiala
1Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA. rjschmidt@ucdavis.edu
Insights
Maternal prenatal vitamin use around conception may lower autism risk, particularly for mothers and children with specific genetic factors. Further research is needed to confirm these findings.
Area of Science:
- Neurodevelopmental disorders
- Genetics and environment in autism
- Nutritional epidemiology
Background:
- The etiology of autism spectrum disorder (ASD) remains largely unknown.
- Maternal nutritional factors and their interactions with genetic predispositions are under-investigated in ASD.
- Understanding these factors is crucial for identifying potential preventative strategies.
Purpose of the Study:
- To investigate the association between maternal prenatal vitamin intake and autism risk.
- To explore potential gene-environment interactions between maternal nutritional status and genetic variants in the one-carbon metabolism pathway.
- To identify specific genetic susceptibilities that may modify the effect of prenatal vitamins on autism risk.
Main Methods:
- Population-based case-control study (CHARGE) involving families with children aged 24-60 months.
- Retrospective data collection on maternal vitamin intake (periconceptional period).
- Analysis of gene-environment interactions using functional genetic variants in one-carbon metabolism (e.g., MTHFR, COMT, CBS) in mothers and children.
Main Results:
- Mothers of children with autism were less likely to report prenatal vitamin use before and during early pregnancy (OR=0.62).
- Significant interactions indicated increased autism risk with no prenatal vitamin intake in mothers carrying specific MTHFR, CBS, or COMT genotypes, or in children with certain COMT genotypes.
- Children with mothers possessing other one-carbon metabolism gene variants also showed increased risk when prenatal vitamin intake was not reported.
Conclusions:
- Periconceptional prenatal vitamin supplementation may be a protective factor against autism.
- The protective effect may be more pronounced in genetically susceptible mother-child pairs.
- Further studies are recommended for replication and to elucidate underlying biological mechanisms.
Background:
Causes of autism are unknown. Associations with maternal nutritional factors and their interactions with gene variants have not been reported.
Methods:
Northern California families were enrolled from 2003 to 2009 in the CHARGE (CHildhood Autism Risks from Genetics and Environment) population-based case-control study. Children aged 24-60 months were evaluated and confirmed to have autism (n = 288), autism spectrum disorder (n = 141), or typical development (n = 278) at the University of California-Davis Medical Investigation of Neurodevelopmental Disorders Institute using standardized clinical assessments. We calculated adjusted odds ratios (ORs) for associations between autism and retrospectively collected data on maternal vitamin intake before and during pregnancy. We explored interaction effects with functional genetic variants involved in one-carbon metabolism (MTHFR, COMT, MTRR, BHMT, FOLR2, CBS, and TCN2) as carried by the mother or child.
Results:
Mothers of children with autism were less likely than those of typically developing children to report having taken prenatal vitamins during the 3 months before pregnancy or the first month of pregnancy (OR = 0.62 [95% confidence interval = 0.42-0.93]). Significant interaction effects were observed for maternal MTHFR 677 TT, CBS rs234715 GT + TT, and child COMT 472 AA genotypes, with greater risk for autism when mothers did not report taking prenatal vitamins periconceptionally (4.5 [1.4-14.6]; 2.6 [1.2-5.4]; and 7.2 [2.3-22.4], respectively). Greater risk was also observed for children whose mothers had other one-carbon metabolism pathway gene variants and reported no prenatal vitamin intake.
Conclusions:
Periconceptional use of prenatal vitamins may reduce the risk of having children with autism, especially for genetically susceptible mothers and children. Replication and mechanistic investigations are warranted.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Principles of Pharmacogenetics: Types of Genetic Variants
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Cancer Prevention
Some...
Inborn Errors of Metabolism


